1. High re-revision rate following one-stage exchange for streptococcal periprosthetic joint infection of the hip
- Author
-
Malte Ohlmeier, Nael Hawi, Mustafa Citak, Carl Haasper, Insa Jachczik, Hussein Abdelaziz, and Thorsten Gehrke
- Subjects
Reoperation ,Arthritis, Infectious ,030222 orthopedics ,medicine.medical_specialty ,Prosthesis-Related Infections ,business.industry ,Arthroplasty, Replacement, Hip ,Periprosthetic ,One stage ,Anti-Bacterial Agents ,Surgery ,03 medical and health sciences ,Treatment Outcome ,0302 clinical medicine ,Streptococcal Infections ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Revision rate ,030212 general & internal medicine ,business ,Retrospective Studies ,Total hip arthroplasty - Abstract
Introduction: This study was undertaken to analyse the outcome of 1-stage exchange in the management of streptococcal periprosthetic joint infection (PJI) of the hip at a single hospital. Methods: We identified 30 patients with a streptococcal PJI of the hip who had been treated by 1-stage exchange at our hospital between 2002 and 2017. Postoperative complications and the need for any subsequent re-revision for infection or other reasons were analysed. The Harris Hip Score (HHS) was evaluated at final follow-up. Results: The mean follow-up was 8.2 years (SD 4.1). The overall re-revision rate for any reason was 53% (16/30) at a mean 5.3 years (SD 0.68 years). Re-revision for infection was 20% (6/30) at a mean 1.8 years (SD 0.74 years). All re-revisions for PJI (6/6; 100%) were for relapse of the streptococcal infection. At final follow-up, the mean HHS was 68 points (SD 20). Conclusions: The rate of re-revision after 1-stage exchange for streptococcal PJI is high. Eradication of a streptococcal PJI of the hip remains challenging. Further extensive and comparative studies between 1-and 2-stage exchange are encouraged.
- Published
- 2021
- Full Text
- View/download PDF